Signaturefd, LLC Regenxbio Inc. Transaction History
Signaturefd, LLC
- $5.21 Billion
- Q4 2024
A detailed history of Signaturefd, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 2,083 shares of RGNX stock, worth $15,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,083
Previous 2,000
4.15%
Holding current value
$15,205
Previous $20,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RGNX
# of Institutions
190Shares Held
44.2MCall Options Held
159KPut Options Held
40.7K-
Black Rock Inc. New York, NY8.61MShares$62.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.79MShares$35 Million2.9% of portfolio
-
Jpmorgan Chase & CO New York, NY4.14MShares$30.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$21.8 Million0.0% of portfolio
-
State Street Corp Boston, MA2.19MShares$16 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $316M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...